GLP‑1 receptor agonists: the weight‑loss wonder drugs that started as diabetes meds
Ozempic, Wegovy, Mounjaro — you've heard the hype. These GLP‑1 receptor agonists were developed for diabetes, but they cause dramatic weight loss. The diabetes drug market research shows that GLP‑1s are the fastest‑growing drug class, with a CAGR above 10%. Why? Because they not only lower blood sugar but also reduce appetite, slow stomach emptying, and even protect the...
0 Comments 0 Shares 24 Views 0 Reviews
MakeMyFriends https://makemyfriends.com